Literature DB >> 12883552

Enhanced T cell responses due to diacylglycerol kinase zeta deficiency.

Xiao-Ping Zhong1, Ehmonie A Hainey, Benjamin A Olenchock, Martha S Jordan, Jonathan S Maltzman, Kim E Nichols, Hao Shen, Gary A Koretzky.   

Abstract

Much is known about how T cell receptor (TCR) engagement leads to T cell activation; however, the mechanisms terminating TCR signaling remain less clear. Diacylglycerol, generated after TCR ligation, is essential in T cells. Its function must be controlled tightly to maintain normal T cell homeostasis. Previous studies have shown that diacylglycerol kinase zeta (DGKzeta), which converts diacylglycerol to phosphatidic acid, can inhibit TCR signaling. Here we show that DGKzeta-deficient T cells are hyperresponsive to TCR stimulation both ex vivo and in vivo. Furthermore, DGKzeta-deficient mice mounted a more robust immune response to lymphocytic choriomeningitis virus infection than did wild-type mice. These results demonstrate the importance of DGKzeta as a physiological negative regulator of TCR signaling and T cell activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12883552     DOI: 10.1038/ni958

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  114 in total

1.  The death effector domain protein PEA-15 negatively regulates T-cell receptor signaling.

Authors:  Sandra Pastorino; Hemamalini Renganathan; Maisel J Caliva; Erin L Filbert; John Opoku-Ansah; Florian J Sulzmaier; Joanna E Gawecka; Guy Werlen; Andrey S Shaw; Joe W Ramos
Journal:  FASEB J       Date:  2010-03-30       Impact factor: 5.191

2.  Critical roles of RasGRP1 for invariant NKT cell development.

Authors:  Shudan Shen; Yong Chen; Balachandra K Gorentla; Jianxin Lu; James C Stone; Xiao-Ping Zhong
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

3.  TCR signaling intensity controls CD8+ T cell responsiveness to TGF-β.

Authors:  Vidhyalakshmi Arumugam; Theresa Bluemn; Erin Wesley; Amanda M Schmidt; Taku Kambayashi; Subramaniam Malarkannan; Matthew J Riese
Journal:  J Leukoc Biol       Date:  2015-07-07       Impact factor: 4.962

4.  Diacylglycerol kinase ζ is a negative regulator of GPVI-mediated platelet activation.

Authors:  Alyssa J Moroi; Nicole M Zwifelhofer; Matthew J Riese; Debra K Newman; Peter J Newman
Journal:  Blood Adv       Date:  2019-04-09

5.  Differential regulation of primary and memory CD8 T cell immune responses by diacylglycerol kinases.

Authors:  Jinwook Shin; Thomas F O'Brien; Jason M Grayson; Xiao-Ping Zhong
Journal:  J Immunol       Date:  2012-01-23       Impact factor: 5.422

6.  Exosomes Represent an Immune Suppressive T Cell Checkpoint in Human Chronic Inflammatory Microenvironments.

Authors:  Gautam N Shenoy; Maulasri Bhatta; Jenni L Loyall; Raymond J Kelleher; Joel M Bernstein; Richard B Bankert
Journal:  Immunol Invest       Date:  2020-04-17       Impact factor: 3.657

7.  Diacylglycerol kinase ζ limits the generation of natural regulatory T cells.

Authors:  Amanda M Schmidt; Tao Zou; Rohan P Joshi; Theresa M Leichner; Matthew A Pimentel; Connie L Sommers; Taku Kambayashi
Journal:  Sci Signal       Date:  2013-11-26       Impact factor: 8.192

8.  The ζ isoform of diacylglycerol kinase plays a predominant role in regulatory T cell development and TCR-mediated ras signaling.

Authors:  Rohan P Joshi; Amanda M Schmidt; Jayajit Das; Dariusz Pytel; Matthew J Riese; Melissa Lester; J Alan Diehl; Edward M Behrens; Taku Kambayashi; Gary A Koretzky
Journal:  Sci Signal       Date:  2013-11-26       Impact factor: 8.192

9.  Histone deacetylase 7 functions as a key regulator of genes involved in both positive and negative selection of thymocytes.

Authors:  Herbert G Kasler; Eric Verdin
Journal:  Mol Cell Biol       Date:  2007-04-30       Impact factor: 4.272

Review 10.  New insights into the regulation and function of serine/threonine kinases in T lymphocytes.

Authors:  Sharon A Matthews; Doreen A Cantrell
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.